HCM - Tingkat wutah pendapatan YoY sajrone rolas wulan kepungkur hutch-med.com

Logo perusahaan publik HUTCHMED Corp (HCM)

HUTCHMED (China) Limited's TTM annual revenue growth rate correlates with the expansion of fruquintinib and the alliance with Takeda, while -8.90 shows the value of this parameter. Environmental responsibility is demonstrated through energy-efficient plants and wastewater treatment. Business stability relies on the success of clinical trials in the US and China, coupled with strict control over R&D expenses.

Wutah pendapatan YoY sajrone 12 wulan kepungkur Hutchison MediPharma (HCM): kanggo periode 11.02.2024 - 18.11.2026

HUTCHMED (HCM) - rincian metrik lan laporan keuangan

- nilai pasar lan prakiraan target analis:
Ringkesan analitik perusahaan:HUTCHMED (China) Limited
Sampel barang hutch-med.com

A fundamental valuation of HUTCHMED (China) Limited (HCM) requires an analysis of the scaling rates of its innovative drug portfolio. This indicator measures daily revenue dynamics over a rolling year, capturing operational activity and identifying stagnation or anomalous spikes. By analyzing this chart of 12-month YoY sales changes, an investor can discern the expansion speed of targeted therapies across global markets. Growth in this metric confirms the commercial success of oncology developments, although extreme peaks may signal currency risks.

Pesaing HUTCHMED (China) Limited (HCM)

Incyte Pharma - Wutah dodolan YoY sajrone rolas wulan kepungkur|NUVB - Wutah dodolan YoY sajrone rolas wulan kepungkur|Wutah pendapatan taun lumaku Day One|MNPR: Wutah dodolan YoY (TTM)|Tingkat wutah pendapatan YoY sajrone rolas wulan kepungkur Inhibrx Biosciences Inc INBX|Wutah pendapatan YoY sajrone 12 wulan kepungkur IMAB|Wutah pendapatan taun lumaku Fennec Pharmaceuticals FENC|Wutah pendapatan YoY sajrone 12 wulan kepungkur HRTX (Heron)|NVCT (Nuvectis Pharma) - Dinamika pendapatan YoY sajrone rolas wulan kepungkur|Coherus Biosciences - Wutah pendapatan YoY sajrone 12 wulan kepungkur|Owah-owahan pendapatan YoY sajrone 12 wulan kepungkur CRBP (Corbus Pharmaceuticals Holdings)|Cardiff Oncology - Wutah dodolan YoY (TTM)|Dinamika pendapatan YoY sajrone rolas wulan kepungkur BYSI (BeyondSpring Pharma)|BCAB: Wutah dodolan YoY (TTM)|Wutah pendapatan taun lumaku lixte.com (LIXT)|Wutah dodolan YoY sajrone rolas wulan kepungkur citiuspharma.com|CLRB: Dinamika pendapatan YoY sajrone rolas wulan kepungkur|Wutah dodolan YoY (TTM) BLRX|Wutah dodolan YoY (TTM) Can-Fite (CANF)|Wutah dodolan YoY sajrone rolas wulan kepungkur Aprea Therapeutics Inc. APRE|KZIA (kaziatherapeutics.com) - Wutah dodolan taun lumaku|SLXN: Wutah pendapatan YoY sajrone 12 wulan kepungkur|Wutah pendapatan taun lumaku NuCana|CMRX: Wutah dodolan YoY (TTM)|Wutah pendapatan YoY sajrone 12 wulan kepungkur Cyclacel Pharmaceuticals|GTHX (g1therapeutics.com) - Wutah dodolan YoY (TTM)|KRON: Dinamika pendapatan YoY sajrone rolas wulan kepungkur|Wutah dodolan YoY sajrone rolas wulan kepungkur Kintara (KTRA)|Wutah pendapatan YoY sajrone 12 wulan kepungkur Oncternal ONCT|Portage Biotech - Wutah pendapatan YoY sajrone 12 wulan kepungkur